Reducing dropout in treatment for depression: Translating dropout predictors into individualized treatment recommendations

Journal of Clinical Psychiatry

Volumn 77, Issue 12, 2016, Pages e1584-e1590

  Zilcha Mano, Sigal ^a   Keefe, John R ^b   Chui, Harold ^d   Rubin, Avinadav ^a   Barrett, Marna S ^c   Barber, Jacques P ^d  

^a UNIVERSITY OF HAIFA   (Israel)

^b Departments of Psychology   (Israel)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d ADELPHI UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DEPRESSION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT DROPOUT; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SOCIAL ASPECT; SUPPORTIVE EXPRESSIVE THERAPY; TREATMENT RESPONSE; AGE; ANXIETY DISORDER; COMORBIDITY; HUMAN RELATION; MIDDLE AGED; PERSONALITY DISORDER; PROCEDURES; PSYCHOLOGY; PSYCHOTHERAPY; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT DROPOUTS; PERSONALITY DISORDERS; PSYCHOTHERAPY; YOUNG ADULT;

EID: 85007559161     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.15m10081     Document Type: Article

References (56)

1. Lambert MJ. Bergin and Garfields Handbook of Psychotherapy and Behavior Change. New York, NY: John Wiley & Sons; 2013.
2. Swift JK, Greenberg RP. Premature discontinuation in adult psychotherapy: A meta-Analysis. J Consult Clin Psychol. 2012;80(4):547-559. doi:10.1037/a02826
3. Flöckiger C. Multiple strategies to prevent premature termination in psychotherapy. PsycCRITIQUES. 2015;60(22). doi:10.1037/a038612
4. Klein EB, Stone WN, Hicks MW, et al. Understanding dropouts. J Ment Health Couns. 2003;25(2):89-100. doi:10.174/mehc.25.2.xhyregxdcd0q4ny
5. Lampropoulos GK. Type of counseling termination and trainee therapist-client agreement about change. Couns Psychol Q. 2010;23(1):111-120. doi:10.1080/095150710372152
6. Pekarik G. Relationship of clients reasons for dropping out of treatment to outcome and satisfaction. J Clin Psychol. 1992;48(1):91-98. doi:10.102/1097-4679(19201)48:13.0.CO;2-W
7. Cahill J, Barkham M, Hardy G, et al. Outcomes of patients completing and not completing cognitive therapy for depression. Br J Clin Psychol. 2003;42(pt 2):133-143. doi:10.1348/01465032190353
8. Baekeland F, Lundwall L. Dropping out of treatment: A critical review. Psychol Bull. 1975;82(5):738-783. doi:10.1037/h07132
9. Garfield SL. Research on client variables in psychotherapy. In: Bergin AE, Garfield SL, eds. Handbook of Psychotherapy and Behavior Change. 4th ed. New York, NY: Wiley; 1994:190-228.
10. Reis BF, Brown LG. Reducing psychotherapy dropouts: maximizing perspective convergence in the psychotherapy dyad. Psychother Theor Res Pract Train. 1999;36(2):123-136. doi:10.1037/h08782
11. Wierzbicki M, Pekarik G. A meta-Analysis of psychotherapy dropout. Prof Psychol Res Pract. 1993;24(2):190-195. doi:10.1037/0735-7028.24.2.190
12. DeRubeis RJ, Cohen ZD, Forand NR, et al. The Personalized Advantage Index: Translating research on prediction into individualized treatment recommendations, a demonstration. PLoS ONE. 2014;9(1):e83875. doi:10.1371/journal.pone.083875
13. Arnow BA, Blasey C, Manber R, et al. Dropouts versus completers among chronically depressed outpatients. J Affect Disord. 2007;97(1-3):197-202. doi:10.1016/j.jad.206.06.017
14. Khazaie H, Rezaie L, de Jong DM. Dropping out of outpatient psychiatric treatment: A preliminary report of a 2-year follow-up of 1, 500 psychiatric outpatients in Kermanshah, Iran. Gen Hosp Psychiatry. 2013;35(3):314-319. doi:10.1016/j.genhospsych.2012.10.08
15. Warden D, Trivedi MH, Wisniewski SR, et al. Predictors of attrition during initial (citalopram) treatment for depression: A STARD report. Am J Psychiatry. 2007;164(8):1189-1197. doi:10.176/api.ajp.207.0607125
16. Warden D, Rush AJ, Wisniewski SR, et al. What predicts attrition in second step medication treatments for depression? a STAR D report. Int J Neuropsychopharmacol. 2009;12(4):459-473. doi:10.1017/S14614570809073
17. Warden D, Rush AJ, Wisniewski SR, et al. Income and attrition in the treatment of depression: A STAR D report. Depress Anxiety. 2009;26(7):622-633. doi:10.102/da.20541
18. Simpson DD, Joe GW. Motivation as a predictor of early dropout from drug abuse treatment. Psychother Theor Res Pract Train. 1993;30(2):357-368. doi:10.1037/03-3204.30.2.357
19. Swift JK, Callahan JL, Ivanovic M, et al. Further examination of the psychotherapy preference effect: A meta-regression analysis. J Psychother Integration. 2013;23(2):134-145. doi:10.1037/a031423
20. Simon GE, Ludman EJ. Predictors of early dropout from psychotherapy for depression in community practice. Psychiatr Serv. 2010;61(7):684-689. doi:10.176/ps.2010.61.7.684
21. McMurran M, Huband N, Overton E. Noncompletion of personality disorder treatments: A systematic review of correlates, consequences, and interventions. Clin Psychol Rev. 2010;30(3):277-287. doi:10.1016/j.cpr.209.12.02
22. Crawford MJ, Price K, Gordon F, et al. Engagement and retention in specialist services for people with personality disorder. Acta Psychiatr Scand. 2009;119(4):304-311. doi:10.1/j.160-047.208.01306.x
23. Barber JP, Barrett MS, Gallop R, et al. Shortterm dynamic psychotherapy versus pharmacotherapy for major depressive disorder: A randomized, placebo-controlled trial. J Clin Psychiatry. 2012;73(1):66-73. doi:10.408/JCP.1m06831
24. Barth J, Munder T, Gerger H, et al. Comparative efficacy of seven psychotherapeutic interventions for patients with depression: A network meta-Analysis. PLoS Med. 2013;10(5):e1001454. doi:10.1371/journal.pmed.101454
25. Cuijpers P, van Straten A, Andersson G, et al. Psychotherapy for depression in adults: A meta-Analysis of comparative outcome studies. J Consult Clin Psychol. 2008;76(6):909-922. doi:10.1037/a013075
26. Del Re AC, Maisel N, Blodgett JC, et al. Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: A multivariate meta-Analysis examining change over time. J Clin Psychopharmacol. 2013;33(5):649-657. doi:10.1097/JCP.0b013e3182983e73
27. Gartlehner G, Hansen RA, Morgan LC, et al. Comparative benefits and harms of secondgeneration antidepressants for treating major depressive disorder: An updated meta-Analysis. Ann Intern Med. 2011;155(11):772-785. doi:10.7326/03-4819-15-1-2012060-09
28. Rutherford BR, Roose SP. A model of placebo response in antidepressant clinical trials. Am J Psychiatry. 2013;170(7):723-733. doi:10.176/api.ajp.2012.12040474
29. Dinger U, Zilcha-Mano S, McCarthy KS, et al. Interpersonal problems as predictors of alliance, symptomatic improvement and premature termination in treatment of depression. J Affect Disord. 2013;151(2):800-803. doi:10.1016/j.jad.2013.07.03
30. Zilcha-Mano S, Dinger U, McCarthy KS, et al. Changes in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorder. J Affect Disord. 2014;152-154:538-542. doi:10.1016/j.jad.2013.10.015
31. Horowitz LM, Rosenberg SE, Baer BA, et al. Inventory of interpersonal problems: psychometric properties and clinical applications. J Consult Clin Psychol. 1988;56(6):885-892. doi:10.1037/02-06X.56.6.85
32. First MB, Spitzer RL, Gibbon M, et al. The Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P version 2.0). New York, NY: New York State Psychiatric Institute Biometric Research Department; 1995.
33. Luborsky L, Mark D, Hole AV, et al. Supportiveexpressive dynamic psychotherapy of depression: A time-limited version. In: Barber JB, Critis-Christoph P, eds. Dynamic Treatment for Psychiatric Disorders (Axis I). New York, NY: Basic Books; 1995:13-42.
34. Fawcett J, Epstein P, Fiester SJ, et al; NIMH Treatment of Depression Collaborative Research Program. Clinical management-imipramine/placebo administration manual. Psychopharmacol Bull. 1987;23(2):309-324.
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62. doi:10.136/jnp.23.1.56
36. Horvath AO, Greenberg LS. Development and validation of the Working Alliance Inventory. J Couns Psychol. 1989;36(2):223-233. doi:10.1037/02-0167.36.2.23
37. Tracey TJ, Kokotovic AM. Factor structure of the Working Alliance Inventory. Psychol Assess. 1989;1(3):207-210. doi:10.1037/1040-3590.1.3.207
38. Barber JP, Zilcha-Mano S, Gallop R, et al. The associations among improvement and alliance expectations, alliance during treatment, and treatment outcome for major depressive disorder. Psychother Res. 2014;24(3):257-268. doi:10.1080/1050307.2013.871080
39. Sholomskas DE. Interviewing methods. In: Wolman BB, Stircker G, eds. Depressive Disorders: Facts, Theories and Treatment Methods. Oxford, England: John Wiley and Sons; 1990:231-247.
40. Elkin I, Parloff MB, Hadley SW, et al. NIMH treatment of depression collaborative research program: background and research plan. Arch Gen Psychiatry. 1985;42(3):305-316. doi:10.101/archpsyc.1985.01790260103013
41. Garge NR, Bobashev G, Eggleston B. Random forest methodology for model-based recursive partitioning: The mobForest package for R. BMC Bioinformatics. 2013;14(1):125. doi:10.186/1471-2105-14-125
42. Strobl C, Boulesteix AL, Kneib T, et al. Conditional variable importance for random forests. BMC Bioinformatics. 2008;9(1):307. doi:10.186/1471-2105-9-307
43. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat. 1983;37(1):36-48.
44. Rubin DB. Comment: simulation in hierarchical models. J Am Stat Assoc. 1987;82(398):543-546.
45. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really needed? some practical clarifications of multiple imputation theory. Prev Sci. 2007;8(3):206-213. doi:10.107/s121-07-070-9
46. Zilcha-Mano S, McCarthy KS, Dinger U, et al. To what extent is alliance affected by transference? an empirical exploration. Psychotherapy (Chic). 2014;51(3):424-433. doi:10.1037/a03656
47. Zilcha-Mano S, McCarthy KS, Dinger U, et al. Are there subtypes of panic disorder? an interpersonal perspective. J Consult Clin Psychol. 2015;83(5):938-950. doi:10.1037/a039373
48. Sharf J, Primavera LH, Diener MJ. Dropout and therapeutic alliance: A meta-Analysis of adult individual psychotherapy. Psychotherapy (Chic). 2010;47(4):637-645. doi:10.1037/a02175
49. Zilcha-Mano S, Barber JP. Instability of depression severity at intake as a moderator of outcome in the treatment for major depressive disorder. Psychother Psychosom. 2014;83(6):382-383.
50. Khan A, Bhat A, Kolts R, et al. Why has the antidepressant-placebo difference in antidepressant clinical trials diminished over the past three decades? CNS Neurosci Ther. 2010;16(4):217-226. doi:10.1/j.175-5949.2010.0151.x
51. Cressey D. Psychopharmacology in crisis. Nature News web site. http://www.nature. com/news/2011/110614/full/news.2011.367.html. Updated June 14, 2011.
52. Khan A, Brown WA. Antidepressants versus placebo in major depression: An overview. World Psychiatry. 2015;14(3):294-300. doi:10.102/wps.20241
53. Roos J, Werbart A. Therapist and relationship factors influencing dropout from individual psychotherapy: A literature review. Psychother Res. 2013;23(4):394-418. doi:10.1080/1050307.2013.7528
54. Werbart A, Andersson H, Sandell R. Dropout revisited: patient-And therapist-initiated discontinuation of psychotherapy as a function of organizational instability. Psychother Res. 2014;24(6):724-737. doi:10.1080/1050307.2014.83087
55. Fava GA, Guidi J, Rafanelli C, et al. The clinical inadequacy of evidence-based medicine and the need for a conceptual framework based on clinical judgment. Psychother Psychosom. 2015;84(1):1-3. doi:10.159/036041
56. Hamburg MA, Collins FS. The path to personalized medicine. N Engl J Med. 2010;363(4):301-304. doi:10.1056/NEJMp106304